Literature DB >> 10206824

Astroglial dysfunction in hepatic encephalopathy.

M D Norenberg1.   

Abstract

While the pathogenesis of hepatic encephalopathy (HE) remains elusive, there is considerable evidence pointing to a key role of ammonia-induced dysfunction of astrocytes in this condition. Deficits in the ability of astrocytes to take up glutamate from the extracellular space may lead to abnormal glutamatergic neurotransmission. Furthermore, excessive stimulation of neuronal and glial glutamate receptors by elevated extracellular levels of glutamate may lead to excitotoxicity and greater glial dysfunction. Ammonia also causes upregulation of astroglial peripheral-type benzodiazepine receptors (PBRs) which is associated with increased production of neurosteroids. These neurosteroids have potent positive modulatory effects on the neuronal GABA(A) receptor which, combined with an ammonia-induced astroglial defect in GABA uptake, may result in enhanced GABAergic tone. Brain edema, associated with fulminant hepatic failure, may also result from astroglial abnormalities as the edema appears to be principally caused by swelling of these cells. Increased amounts of glutamine in astrocytes resulting from elevated brain ammonia levels may be a factor in this swelling. Other osmolytes such as glutathione may also be involved. Glial swelling may also result from NH4+ - and K+ -mediated membrane depolarization as well as by the actions of PBR agonists and neurosteroids. These findings show that an ammonia-induced gliopathy is a major factor in the pathogenesis of HE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10206824     DOI: 10.1023/a:1020688925901

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  119 in total

1.  Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion.

Authors:  R Myers; L G Manjil; B M Cullen; G W Price; R S Frackowiak; J E Cremer
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

Review 2.  Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.

Authors:  A S Basile; E A Jones
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

Review 3.  Neurosteroids and GABAA receptor function.

Authors:  J J Lambert; D Belelli; C Hill-Venning; J A Peters
Journal:  Trends Pharmacol Sci       Date:  1995-09       Impact factor: 14.819

Review 4.  Astrocyte-neuron interactions in hyperammonemia and hepatic encephalopathy.

Authors:  J Albrecht; L Faff
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

5.  L-methionine-DL-sulfoximine induces massive efflux of glutamine from cortical astrocytes in primary culture.

Authors:  J Albrecht; M D Norenberg
Journal:  Eur J Pharmacol       Date:  1990-07-17       Impact factor: 4.432

6.  Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain.

Authors:  Y Itzhak; A Roig-Cantisano; R S Dombro; M D Norenberg
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

7.  The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem.

Authors:  E Pileblad; P S Eriksson; E Hansson
Journal:  J Neural Transm Gen Sect       Date:  1991

8.  Expression of glutamate transporters in cultured glial cells.

Authors:  K Kondo; H Hashimoto; J Kitanaka; M Sawada; A Suzumura; T Marunouchi; A Baba
Journal:  Neurosci Lett       Date:  1995-03-24       Impact factor: 3.046

9.  Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat.

Authors:  K N Oppong; K Bartlett; C O Record; H al Mardini
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  40 in total

Review 1.  The basal ganglia and portal-systemic encephalopathy.

Authors:  K Weissenborn; H Kolbe
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

2.  Rabbit retinal organ culture as an in-vitro model of hepatic retinopathy.

Authors:  Heidrun Kuhrt; Michał Walski; Andreas Reichenbach; Jan Albrecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

Review 3.  Functional imaging of the brain in patients with liver cirrhosis.

Authors:  Karin Weissenborn; Martin Bokemeyer; Björn Ahl; Daniela Fischer-Wasels; Kathrin Giewekemeyer; Jörg van den Hoff; Herbert Köstler; Georg Berding
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 4.  Energy metabolism in brain cells: effects of elevated ammonia concentrations.

Authors:  Leif Hertz; Geeta Kala
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 6.  Signaling factors in the mechanism of ammonia neurotoxicity.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

Review 7.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

8.  Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.

Authors:  Maria E Sobaniec-Lotowska
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

9.  Potentiation by thrombin of hyposmotic glutamate and taurine efflux from cultured astrocytes: signalling chains.

Authors:  S Cruz-Rangel; R Hernández-Benítez; E Vázquez-Juárez; A López-Dominguez; H Pasantes-Morales
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

10.  Hepatic encephalomyelopathy in a calf with congenital portosystemic shunt (CPSS).

Authors:  Valéria Café Marçal; Anna Oevermann; Tim Bley; Patrizia Pfister; Julien Miclard
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.